Mutations for decreasing the immunogenicity and maintaining the function of core streptavidin

Area of Science:

• Biochemistry
• Protein Engineering
• Immunology

Background:

• Core streptavidin (cSA) exhibits high biotin affinity and stability, making it attractive for applications.
• However, its bacterial origin leads to high immunogenicity, hindering clinical use.
• Previous work generated hypoimmunogenic cSA muteins, but their physicochemical properties required further investigation.

Purpose of the Study:

• To investigate the physicochemical properties and functions of previously engineered hypoimmunogenic cSA muteins.
• To determine if mutations affecting immunogenicity impact protein stability, structure, and biotin-binding capability.
• To explore mechanisms for creating hypoimmunogenic proteins with retained functionality.

Main Methods:

• Isothermal titration calorimetry (ITC) to assess binding thermodynamics.
• Differential scanning calorimetry (DSC) for thermal stability analysis.
• Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to evaluate protein structure and integrity.

Main Results:

• The hypoimmunogenic cSA muteins successfully retained their biotin-binding function.
• Structural analysis confirmed that the muteins maintain the stable tetrameric structure characteristic of wild-type cSA.
• Physicochemical characterization indicated no significant detrimental effects on core properties despite mutations for hypoimmunogenicity.

Conclusions:

• Engineered hypoimmunogenic cSA muteins preserve essential functions and structural integrity.
• The mutations successfully reduced immunogenicity without compromising core streptavidin's key properties.
• These findings support a novel strategy for designing hypoimmunogenic proteins for therapeutic applications.